Tatsuya Ioka
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research 92
- Colorectal Cancer Treatments and Studies 11
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 28
- Hepatology top 5%
-
- Gallbladder and Bile Duct Disorders 30
- Renal cell carcinoma treatment 10
- Surgery top 2%
- Cholangiocarcinoma and Gallbladder Cancer Studies 47
- Pancreatitis Pathology and Treatment 20
-
- Neuroendocrine Tumor Research Advances 26
- Co-authors
- Junji FuruseSachiko TanakaTakuji OkusakaMasafumi IkedaHiroyuki UeharaShinichi OhkawaOsamu OshikawaMakoto Ueno
- Cited by
- OncologyCancer ResearchHepatology
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Tatsuya Ioka
154 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 115
- Oncology 2.1k
- Cancer Research 624
- Hepatology 263
- Pulmonary and Respiratory Medicine 1.0k
- Surgery 1.3k
Countries citing papers authored by Tatsuya Ioka
This map shows the geographic impact of Tatsuya Ioka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsuya Ioka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsuya Ioka more than expected).
Fields of papers citing papers by Tatsuya Ioka
This network shows the impact of papers produced by Tatsuya Ioka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsuya Ioka. The network helps show where Tatsuya Ioka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tatsuya Ioka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 1 | |
| 8 | [A Case in Which FOLFOXIRI Was Useful as Preoperative Chemotherapy for Locally Advanced Rectal Cancer with Difficulty in Securing CRM]. | 2022 | 0 |
| 9 | 2022 | 8 | |
| 10 | 2022 | 3 | |
| 11 | 2018 | 3 | |
| 12 | 2018 | 8 | |
| 13 | 2017 | 8 | |
| 14 | 2012 | 7 | |
| 15 | 2011 | 43 | |
| 16 | 2011 | 62 | |
| 17 | 2011 | 4 | |
| 18 | 1996 | 18 | |
| 19 | 1995 | 4 | |
| 20 | 1989 | 2 |
About Tatsuya Ioka
Tatsuya Ioka is a scholar working on Oncology, Cancer Research and Surgery, having authored 166 papers that have together received 3.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (92 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (47 papers), Gallbladder and Bile Duct Disorders (30 papers), Cancer Genomics and Diagnostics (28 papers), Neuroendocrine Tumor Research Advances (26 papers), Pancreatitis Pathology and Treatment (20 papers), Colorectal Cancer Treatments and Studies (11 papers) and Renal cell carcinoma treatment (10 papers). The work is most often cited by research in Oncology (2.1k citations), Cancer Research (624 citations) and Hepatology (263 citations). Tatsuya Ioka has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Junji Furuse, Sachiko Tanaka, Takuji Okusaka, Masafumi Ikeda, Hiroyuki Uehara, Shinichi Ohkawa, Osamu Oshikawa, Makoto Ueno, Eric Van Cutsem and Harpreet Wasan. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.